|
1
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2018. CA Cancer J Clin. 68:7–30. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Rahib L, Smith BD, Aizenberg R, Rosenzweig
AB, Fleshman JM and Matrisian LM: Projecting cancer incidence and
deaths to 2030: The unexpected burden of thyroid, liver, and
pancreas cancers in the United States. Cancer Res. 74:2913–2921.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kamisawa T, Wood LD, Itoi T and Takaori K:
Pancreatic cancer. Lancet. 388:73–85. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Heestand GM, Murphy JD and Lowy AM:
Approach to patients with pancreatic cancer without detectable
metastases. J Clin Oncol. 33:1770–1778. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ferrone CR, Brennan MF, Gonen M, Coit DG,
Fong Y, Chung S, Tang L, Klimstra D and Allen PJ: Pancreatic
adenocarcinoma: The actual 5-year survivors. J Gastrointest Surg.
12:701–706. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Katz MH, Wang H, Fleming JB, Sun CC, Hwang
RF, Wolff RA, Varadhachary G, Abbruzzese JL, Crane CH, Krishnan S,
et al: Long-term survival after multidisciplinary management of
resected pancreatic adenocarcinoma. Ann Surg Oncol. 16:836–847.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Cameron JL and He J: Two thousand
consecutive pancreaticoduodenectomies. J Am Coll Surg. 220:530–536.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Allen PJ, Kuk D, Castillo CF, et al:
Multi-institutional Validation Study of the American Joint
Commission on Cancer (8th Edition) Changes for T and N Staging in
Patients With Pancreatic Adenocarcinoma. Ann Surg. 265:185–191.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chatterjee D, Katz MH, Foo WC, Sundar M,
Wang H, Varadhachary GR, Wolff RA, Lee JE, Maitra A, Fleming JB, et
al: Prognostic Significance of New AJCC Tumor Stage in Patients
With Pancreatic Ductal Adenocarcinoma Treated With Neoadjuvant
Therapy. Am J Surg Pathol. 41:1097–1104. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Rochefort MM, Ankeny JS, Kadera BE, Donald
GW, Isacoff W, Wainberg ZA, Hines OJ, Donahue TR, Reber HA and
Tomlinson JS: Impact of tumor grade on pancreatic cancer prognosis:
Validation of a novel TNMG staging system. Ann Surg Oncol.
20:4322–4329. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yuan C, Morales-Oyarvide V, Babic A, Clish
CB, Kraft P, Bao Y, Qian ZR, Rubinson DA, Ng K, Giovannucci EL, et
al: Cigarette Smoking and Pancreatic Cancer Survival. J Clin Oncol.
35:1822–1828. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ferrone CR, Kattan MW, Tomlinson JS,
Thayer SP, Brennan MF and Warshaw AL: Validation of a postresection
pancreatic adenocarcinoma nomogram for disease-specific survival. J
Clin Oncol. 23:7529–7535. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Barhli A, Cros J, Bartholin L and
Neuzillet C: Prognostic stratification of resected pancreatic
ductal adenocarcinoma: Past, present, and future. Dig Liver Dis.
50:979–990. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ballehaninna UK and Chamberlain RS: The
clinical utility of serum CA 19-9 in the diagnosis, prognosis and
management of pancreatic adenocarcinoma: An evidence based
appraisal. J Gastrointest Oncol. 3:105–119. 2012.PubMed/NCBI
|
|
16
|
Humphris JL, Chang DK, Johns AL, Scarlett
CJ, Pajic M, Jones MD, Colvin EK, Nagrial A, Chin VT, Chantrill LA,
et al NSW Pancreatic Cancer Network, : The prognostic and
predictive value of serum CA19.9 in pancreatic cancer. Ann Oncol.
23:1713–1722. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Albert JM, Liu DD, Shen Y, Pan IW, Shih
YC, Hoffman KE, Buchholz TA, Giordano SH and Smith BD: Nomogram to
predict the benefit of radiation for older patients with breast
cancer treated with conservative surgery. J Clin Oncol.
30:2837–2843. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yi M, Meric-Bernstam F, Kuerer HM,
Mittendorf EA, Bedrosian I, Lucci A, Hwang RF, Crow JR, Luo S and
Hunt KK: Evaluation of a breast cancer nomogram for predicting risk
of ipsilateral breast tumor recurrences in patients with ductal
carcinoma in situ after local excision. J Clin Oncol. 30:600–607.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Tendulkar RD, Agrawal S, Gao T, Efstathiou
JA, Pisansky TM, Michalski JM, Koontz BF, Hamstra DA, Feng FY,
Liauw SL, et al: Contemporary Update of a Multi-Institutional
Predictive Nomogram for Salvage Radiotherapy After Radical
Prostatectomy. J Clin Oncol. 34:3648–3654. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Nam RK, Kattan MW, Chin JL, Trachtenberg
J, Singal R, Rendon R, Klotz LH, Sugar L, Sherman C, Izawa J, et
al: Prospective multi-institutional study evaluating the
performance of prostate cancer risk calculators. J Clin Oncol.
29:2959–2964. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Iasonos A, Schrag D, Raj GV and Panageas
KS: How to build and interpret a nomogram for cancer prognosis. J
Clin Oncol. 26:1364–1370. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhang ZY, Luo QF, Yin XW, Dai ZL, Basnet S
and Ge HY: Nomograms to predict survival after colorectal cancer
resection without preoperative therapy. BMC Cancer. 16:6582016.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Brennan MF, Kattan MW, Klimstra D and
Conlon K: Prognostic nomogram for patients undergoing resection for
adenocarcinoma of the pancreas. Ann Surg. 240:293–298. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Song W, Miao DL and Chen L: Nomogram for
predicting survival in patients with pancreatic cancer. OncoTargets
Ther. 11:539–545. 2018. View Article : Google Scholar
|
|
25
|
Pu N, Li J, Xu Y, Lee W, Fang Y, Han X,
Zhao G, Zhang L, Nuerxiati A, Yin H, et al: Comparison of
prognostic prediction between nomogram based on lymph node ratio
and AJCC 8th staging system for patients with resected pancreatic
head carcinoma: A SEER analysis. Cancer Manag Res. 10:227–238.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
He C, Zhang Y, Cai Z, Lin X and Li S:
Overall survival and cancer-specific survival in patients with
surgically resected pancreatic head adenocarcinoma: A competing
risk nomogram analysis. J Cancer. 9:3156–3167. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
He C, Zhong L, Zhang Y, Cai Z and Lin X:
Development and validation of a nomogram to predict liver
metastasis in patients with pancreatic ductal adenocarcinoma: A
large cohort study. Cancer Manag Res. 11:3981–3991. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Chun YS, Pawlik TM and Vauthey JN: 8th
Edition of the AJCC Cancer Staging Manual: Pancreas and
Hepatobiliary Cancers. Ann Surg Oncol. 25:845–847. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Camp RL, Dolled-Filhart M and Rimm DL:
X-tile: A new bio-informatics tool for biomarker assessment and
outcome-based cut-point optimization. Clin Cancer Res.
10:7252–7259. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wasif N, Ko CY, Farrell J, Wainberg Z,
Hines OJ, Reber H and Tomlinson JS: Impact of tumor grade on
prognosis in pancreatic cancer: Should we include grade in AJCC
staging? Ann Surg Oncol. 17:2312–2320. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Huang L, Balavarca Y, van der Geest L,
Lemmens V, Van Eycken L, De Schutter H, Johannesen TB, Zadnik V,
Primic-Žakelj M, Mägi M, et al: Development and validation of a
prognostic model to predict the prognosis of patients who underwent
chemotherapy and resection of pancreatic adenocarcinoma: A large
international population-based cohort study. BMC Med. 17:662019.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Diwakarla C, Hannan K, Hein N and Yip D:
Advanced pancreatic ductal adenocarcinoma - Complexities of
treatment and emerging therapeutic options. World J Gastroenterol.
23:2276–2285. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Fang C, Wang W, Feng X, Sun J, Zhang Y,
Zeng Y, Wang J, Chen H, Cai M, Lin J, et al: Nomogram individually
predicts the overall survival of patients with
gastroenteropancreatic neuroendocrine neoplasms. Br J Cancer.
117:1544–1550. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Liang W, Zhang L, Jiang G, Wang Q, Liu L,
Liu D, Wang Z, Zhu Z, Deng Q, Xiong X, et al: Development and
validation of a nomogram for predicting survival in patients with
resected non-small-cell lung cancer. J Clin Oncol. 33:861–869.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
de Castro SM, Biere SS, Lagarde SM, Busch
OR, van Gulik TM and Gouma DJ: Validation of a nomogram for
predicting survival after resection for adenocarcinoma of the
pancreas. Br J Surg. 96:417–423. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
He C, Zhang Y, Cai Z, Duan F, Lin X and Li
S: Nomogram to Predict Cancer-Specific Survival in Patients with
Pancreatic Acinar Cell Carcinoma: A Competing Risk Analysis. J
Cancer. 9:4117–4127. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Hlavsa J, Cecka F, Zaruba P, Zajak J,
Gurlich R, Strnad R, Pavlik T, Kala Z and Lovecek M: Tumor grade as
significant prognostic factor in pancreatic cancer: Validation of a
novel TNMG staging system. Neoplasma. 65:637–643. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Garcea G, Dennison AR, Ong SL, et al:
Tumour characteristics predictive of survival following resection
for ductal adenocarcinoma of the head of pancreas. Eur J Surg
Oncol. 33:892–897. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Mannell A, van Heerden JA, Weiland LH and
Ilstrup DM: Factors influencing survival after resection for ductal
adenocarcinoma of the pancreas. Ann Surg. 203:403–407. 1986.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Tsuchiya R, Oribe T and Noda T: Size of
the tumor and other factors influencing prognosis of carcinoma of
the head of the pancreas. Am J Gastroenterol. 80:459–462.
1985.PubMed/NCBI
|
|
41
|
Nagakawa T, Sanada H, Inagaki M, Sugama J,
Ueno K, Konishi I, Ohta T, Kayahara M and Kitagawa H: Long-term
survivors after resection of carcinoma of the head of the pancreas:
Significance of histologically curative resection. J Hepatobiliary
Pancreat Surg. 11:402–408. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Winter JM, Yeo CJ and Brody JR:
Diagnostic, prognostic, and predictive biomarkers in pancreatic
cancer. J Surg Oncol. 107:15–22. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Itzkowitz SH, Yuan M, Fukushi Y, Lee H,
Shi ZR, Zurawski V Jr, Hakomori S and Kim YS: Immunohistochemical
comparison of Lea, monosialosyl Lea (CA 19-9), and disialosyl Lea
antigens in human colorectal and pancreatic tissues. Cancer Res.
48:3834–3842. 1988.PubMed/NCBI
|
|
44
|
Brown EG, Canter RJ and Bold RJ:
Preoperative CA 19-9 kinetics as a prognostic variable in
radiographically resectable pancreatic adenocarcinoma. J Surg
Oncol. 111:293–298. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Sakamoto T, Saito H, Amisaki M, Tokuyasu
N, Honjo S and Fujiwara Y: Combined preoperative
platelet-to-lymphocyte ratio and serum carbohydrate antigen 19-9
level as a prognostic factor in patients with resected pancreatic
cancer. Hepatobiliary Pancreat Dis Int. 18:278–284. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Landi F, Dopazo C, Sapisochin G, Beisani
M, Blanco L, Caralt M, Balsells J and Charco R: Long-term results
of pancreaticoduodenectomy with superior mesenteric and portal vein
resection for ductal adenocarcinoma in the head of the pancreas.
Cir Esp. 93:522–529. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Takagi C, Kikuchi Y, Shirakawa H,
Hoshimoto S, Tomikawa M, Ozawa I, Hishinuma S and Ogata Y:
Predictive Factors for Elevated Postoperative Carbohydrate Antigen
19-9 Levels in Patients With Resected Pancreatic Cancer. Anticancer
Res. 39:3177–3183. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Aoki S, Motoi F, Murakami Y, Sho M, Satoi
S, Honda G, Uemura K, Okada KI, Matsumoto I, Nagai M, et al;
Multicenter Study Group of Pancreatobiliary Surgery (MSG-PBS), .
Decreased serum carbohydrate antigen 19-9 levels after neoadjuvant
therapy predict a better prognosis for patients with pancreatic
adenocarcinoma: A multicenter case-control study of 240 patients.
BMC Cancer. 19:2522019. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Imaoka H, Shimizu Y, Senda Y, et al:
Post-adjuvant chemotherapy CA19-9 levels predict prognosis in
patients with pancreatic ductal adenocarcinoma: A retrospective
cohort study. Pancreatology. 16:658–664. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Deng QL, Dong S, Wang L, Zhang CY, Ying
HF, Li ZS, Shen XH, Guo YB, Meng ZQ, Yu JM, et al: Development and
Validation of a Nomogram for Predicting Survival in Patients with
Advanced Pancreatic Ductal Adenocarcinoma. Sci Rep. 7:115242017.
View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Mitra A, Pai E, Dusane R, Ranganathan P,
DeSouza A, Goel M and Shrikhande SV: Extended pancreatectomy as
defined by the ISGPS: Useful in selected cases of pancreatic cancer
but invaluable in other complex pancreatic tumors. Langenbecks Arch
Surg. 403:203–212. 2018.PubMed/NCBI
|
|
52
|
Homeyer RS, Roberts KJ, Sutcliffe RP,
Kaltenborn A, Mirza D, Qu Z, Klempnauer J and Schrem H: Ventilation
after pancreaticoduodenectomy increases perioperative mortality:
Identification of risk factors and their relevance in Germany that
do not apply in England. Hepatobiliary Pancreat Dis Int.
18:379–388. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Petrou A, Soonawalla Z, Silva MA, et al:
Prognostic indicators following curative pancreatoduodenectomy for
pancreatic carcinoma: A retrospective multivariate analysis of a
single centre experience. J BUON. 21:874–882. 2016.PubMed/NCBI
|
|
54
|
Hwang HK, Jung MJ, Lee SH, Kang CM and Lee
WJ: Adverse oncologic effects of intraoperative transfusion during
pancreatectomy for left-sided pancreatic cancer: The need for
strict transfusion policy. J Hepatobiliary Pancreat Sci.
23:497–507. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Hoh H, Umpleby H, Cooper A and Taylor I:
Recurrence of colorectal cancer and perioperative blood
transfusion. Is blood storage time important? Dis Colon Rectum.
33:127–130. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Park SJ, Kim SW, Jang JY, Lee KU and Park
YH: Intraoperative transfusion: Is it a real prognostic factor of
periampullary cancer following pancreatoduodenectomy? World J Surg.
26:487–492. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Fitzgerald TL, Hunter L, Mosquera C,
Jindal C, Biswas T, Zervos E and Efird JT: A simple matrix to
predict treatment success and long-term survival among patients
undergoing pancreatectomy. HPB (Oxford). 21:204–211. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Ahmad NA, Lewis JD, Ginsberg GG, Haller
DG, Morris JB, Williams NN, Rosato EF and Kochman ML: Long term
survival after pancreatic resection for pancreatic adenocarcinoma.
Am J Gastroenterol. 96:2609–2615. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Morganti AG, Falconi M, van Stiphout RG,
Mattiucci GC, Alfieri S, Calvo FA, Dubois JB, Fastner G, Herman JM,
Maidment BW III, et al: Multi-institutional pooled analysis on
adjuvant chemoradiation in pancreatic cancer. Int J Radiat Oncol
Biol Phys. 90:911–917. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Corsini MM, Miller RC, Haddock MG, Donohue
JH, Farnell MB, Nagorney DM, Jatoi A, McWilliams RR, Kim GP, Bhatia
S, et al: Adjuvant radiotherapy and chemotherapy for pancreatic
carcinoma: The Mayo Clinic experience (1975–2005). J Clin Oncol.
26:3511–3516. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Yegya-Raman N, Shah MM, Grandhi MS, Poplin
E, August DA, Kennedy TJ, Malhotra U, Spencer KR, Carpizo DR and
Jabbour SK: Adjuvant therapeutic strategies for resectable
pancreatic adenocarcinoma. Ann Pancreat Cancer. 1:12018. View Article : Google Scholar
|
|
62
|
Peng D, Li XS, Zhang CJ, et al: Prognostic
factors of patients with T3N0M0 renal cell carcinoma: a
single-center retrospective study of 182 patients. Beijing Da Xue
Xue Bao Yi Xue Ban. 48:806–811. 2016.(In Chinese). PubMed/NCBI
|
|
63
|
Demir IE, Friess H and Ceyhan GO: Neural
plasticity in pancreatitis and pancreatic cancer. Nat Rev
Gastroenterol Hepatol. 12:649–659. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Mantovani A, Allavena P, Sica A and
Balkwill F: Cancer-related inflammation. Nature. 454:436–444. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Grivennikov SI, Greten FR and Karin M:
Immunity, inflammation, and cancer. Cell. 140:883–899. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: The next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Proctor MJ, Morrison DS, Talwar D, Balmer
SM, O'Reilly DS, Foulis AK, Horgan PG and McMillan DC: An
inflammation-based prognostic score (mGPS) predicts cancer survival
independent of tumour site: A Glasgow Inflammation Outcome Study.
Br J Cancer. 104:726–734. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Stotz M, Gerger A, Eisner F, Szkandera J,
Loibner H, Ress AL, Kornprat P, AlZoughbi W, Seggewies FS, Lackner
C, et al: Increased neutrophil-lymphocyte ratio is a poor
prognostic factor in patients with primary operable and inoperable
pancreatic cancer. Br J Cancer. 109:416–421. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Ye S and Bai L: Comparison and validation
of the value of preoperative inflammation marker-based prognostic
scores in resectable pancreatic ductal adenocarcinoma. Cancer Manag
Res. 10:3405–3417. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Zhao W, Wang P, Jia H, Chen M, Gu X, Liu
M, Zhang Z, Cheng W and Wu Z: Neutrophil count and percentage:
Potential independent prognostic indicators for advanced cancer
patients in a palliative care setting. Oncotarget. 8:64499–64508.
2017.PubMed/NCBI
|
|
71
|
He JR, Shen GP, Ren ZF, Qin H, Cui C,
Zhang Y, Zeng YX and Jia WH: Pretreatment levels of peripheral
neutrophils and lymphocytes as independent prognostic factors in
patients with nasopharyngeal carcinoma. Head Neck. 34:1769–1776.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Powell DR and Huttenlocher A: Neutrophils
in the Tumor Microenvironment. Trends Immunol. 37:41–52. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Uribe-Querol E and Rosales C: Neutrophils
in Cancer: Two Sides of the Same Coin. J Immunol Res.
2015:9836982015. View Article : Google Scholar : PubMed/NCBI
|
